ELAVL3 and prostate carcinoma: We then confirmed this result in a panel of prostate cancer cells and consistently observed high basal expression of ELAVL3 in NCI-H660 as well as in the neuroendocrine-associated cell line LASCPC-01, at both the RNA and protein levels (Fig. 1e, f).